Ajooni Biotech enterprise value

·UnclassifiedChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
50.0————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.40.46.80.4—
17.817.81.92.21.7
67.3————
17.317.3−4.91.7—
₹3.91————
10910990.044.9—
16.3%16.3%2.2%4.8%—
0.26×————
0.31×————
9.33×————
15.12×————
Reference items — trailing FY values
21518211580.174.5
7.26.33.72.22.8
4.54.02.61.41.8
—−5.7−17.7−4.0−5.6
−23.8−23.8−20.7−9.6−8.4
—−23.9−20.8−9.7−8.6
—18.03.05.62.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

AJOONI₹2.90

Ajooni Biotech Limited

· Unclassified
₹ CrorePeersTOUCHWOODRKECRAJMETBANKAAAKASHGANGAFORGEGLOBEAGROPHOSMcap ₹50 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————50.0
- Cash, Equiv & ST Investments—0.46.80.40.4
+ Total Debt1.72.21.917.817.8
Enterprise Value————67.3
Net Debt (memo)—1.7-4.917.317.3
EV per Share————3.91
Total Capital—44.990.0109.0109.0
Total Debt/Total Capital—4.832.1516.3016.30
Total Debt/EV————0.26
EV/Sales————0.31
EV/EBITDA————9.33
EV/EBIT————15.12
Reference Items — Trailing FY Values
Sales74.580.1114.7182.4214.6
EBITDA2.82.23.76.37.2
EBIT1.81.42.64.04.5
Operating Cash Flow-5.6-4.0-17.7-5.7—
Free Cash Flow-8.4-9.6-20.7-23.8-23.8
FCFF (free cash flow to the firm)-8.6-9.7-20.8-23.9—
Capital Expenditure2.95.63.018.0—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.